| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | dichotomous subdivision of terminal units involved in salivary gland branching | 2.95e-05 | 5 | 36 | 2 | GO:0060666 | |
| Domain | E3_UB_ligase_RBR | 1.70e-04 | 10 | 37 | 2 | IPR031127 | |
| Domain | IBR | 3.42e-04 | 14 | 37 | 2 | PF01485 | |
| Domain | IBR | 3.42e-04 | 14 | 37 | 2 | SM00647 | |
| Domain | IBR_dom | 3.95e-04 | 15 | 37 | 2 | IPR002867 | |
| Domain | - | 4.77e-04 | 333 | 37 | 5 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 4.90e-04 | 335 | 37 | 5 | IPR015943 | |
| Domain | Semaphorin | 7.09e-04 | 20 | 37 | 2 | IPR027231 | |
| Domain | IG | 1.37e-03 | 421 | 37 | 5 | SM00409 | |
| Domain | Ig_sub | 1.37e-03 | 421 | 37 | 5 | IPR003599 | |
| Domain | SEMA | 1.71e-03 | 31 | 37 | 2 | PS51004 | |
| Domain | Sema | 1.71e-03 | 31 | 37 | 2 | SM00630 | |
| Domain | Semap_dom | 1.71e-03 | 31 | 37 | 2 | IPR001627 | |
| Domain | Sema | 1.71e-03 | 31 | 37 | 2 | PF01403 | |
| Domain | IG_LIKE | 2.68e-03 | 491 | 37 | 5 | PS50835 | |
| Domain | Ig-like_dom | 2.97e-03 | 503 | 37 | 5 | IPR007110 | |
| Domain | PSI | 3.43e-03 | 44 | 37 | 2 | IPR016201 | |
| Domain | PSI | 3.74e-03 | 46 | 37 | 2 | SM00423 | |
| Domain | Ig_2 | 9.19e-03 | 73 | 37 | 2 | PF13895 | |
| Domain | - | 9.45e-03 | 663 | 37 | 5 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.22e-02 | 706 | 37 | 5 | IPR013783 | |
| Domain | WD_REPEATS_1 | 1.75e-02 | 278 | 37 | 3 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.76e-02 | 279 | 37 | 3 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.76e-02 | 279 | 37 | 3 | PS50294 | |
| Pubmed | 4.20e-08 | 7 | 38 | 3 | 15545635 | ||
| Pubmed | Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. | 6.71e-08 | 8 | 38 | 3 | 12852851 | |
| Pubmed | Sequencing analysis of forty-eight human image cDNA clones similar to Drosophila mutant protein. | 6.71e-08 | 8 | 38 | 3 | 10524757 | |
| Pubmed | Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. | 1.44e-07 | 10 | 38 | 3 | 15550623 | |
| Pubmed | 8.10e-07 | 17 | 38 | 3 | 20048339 | ||
| Pubmed | PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. | 1.15e-06 | 19 | 38 | 3 | 15239958 | |
| Pubmed | Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. | 1.16e-06 | 2 | 38 | 2 | 9250681 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17390026 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 1.58e-06 | 21 | 38 | 3 | 36240771 | |
| Pubmed | 2.40e-06 | 24 | 38 | 3 | 23063659 | ||
| Pubmed | Motor innervation directs the correct development of the mouse sympathetic nervous system. | 2.72e-06 | 25 | 38 | 3 | 39152112 | |
| Pubmed | 3.07e-06 | 26 | 38 | 3 | 32467237 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22082309 | ||
| Pubmed | Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. | 3.48e-06 | 3 | 38 | 2 | 12879061 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 20051117 | ||
| Pubmed | Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. | 5.30e-06 | 31 | 38 | 3 | 22076636 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 35994660 | ||
| Pubmed | Sema3a-Nrp1 Signaling Mediates Fast-Twitch Myofiber Specificity of Tw2+ Cells. | 6.96e-06 | 4 | 38 | 2 | 31474563 | |
| Pubmed | Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. | 6.96e-06 | 4 | 38 | 2 | 12730958 | |
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 9811588 | ||
| Pubmed | Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells. | 1.16e-05 | 5 | 38 | 2 | 12068292 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 9331348 | ||
| Pubmed | Distinct roles for S100a8 in early embryo development and in the maternal deciduum. | 1.16e-05 | 5 | 38 | 2 | 22016186 | |
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 18583714 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 19918884 | ||
| Pubmed | 1.16e-05 | 5 | 38 | 2 | 8817451 | ||
| Pubmed | Coronary stem development in wild-type and Tbx1 null mouse hearts. | 1.74e-05 | 6 | 38 | 2 | 26708418 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 22516460 | ||
| Pubmed | Expression of class 3 semaphorins and neuropilin receptors in the developing mouse tooth. | 1.74e-05 | 6 | 38 | 2 | 11231073 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 7748561 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 23709645 | ||
| Pubmed | Notch pathway signaling in the skin antagonizes Merkel cell development. | 1.74e-05 | 6 | 38 | 2 | 29241683 | |
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 11442635 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 23871867 | ||
| Pubmed | 1.74e-05 | 6 | 38 | 2 | 22723300 | ||
| Pubmed | Selective requirements for NRP1 ligands during neurovascular patterning. | 2.43e-05 | 7 | 38 | 2 | 17428830 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 21502490 | ||
| Pubmed | Programmed Cell Senescence in the Mouse Developing Spinal Cord and Notochord. | 2.43e-05 | 7 | 38 | 2 | 33575260 | |
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 31430342 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 16360650 | ||
| Pubmed | 2.43e-05 | 7 | 38 | 2 | 38526535 | ||
| Pubmed | Invariant Sema5A inhibition serves an ensheathing function during optic nerve development. | 3.24e-05 | 8 | 38 | 2 | 12506007 | |
| Pubmed | Sox17 is required for normal pulmonary vascular morphogenesis. | 3.24e-05 | 8 | 38 | 2 | 24418654 | |
| Pubmed | Semaphorins III and IV repel hippocampal axons via two distinct receptors. | 3.24e-05 | 8 | 38 | 2 | 9753685 | |
| Pubmed | 3.24e-05 | 8 | 38 | 2 | 11906695 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 3.24e-05 | 8 | 38 | 2 | 22368082 | |
| Pubmed | Combined in silico and in vivo analyses reveal role of Hes1 in taste cell differentiation. | 4.16e-05 | 9 | 38 | 2 | 19343206 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 8812066 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 16809609 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 14659802 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 37360688 | ||
| Pubmed | A Snail1/Notch1 signalling axis controls embryonic vascular development. | 4.16e-05 | 9 | 38 | 2 | 24894949 | |
| Pubmed | Multiple roles of mouse Numb in tuning developmental cell fates. | 4.16e-05 | 9 | 38 | 2 | 11412999 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 22911783 | ||
| Pubmed | NRP1 Regulates CDC42 Activation to Promote Filopodia Formation in Endothelial Tip Cells. | 5.20e-05 | 10 | 38 | 2 | 26051942 | |
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 30718617 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 21062863 | ||
| Pubmed | 5.20e-05 | 10 | 38 | 2 | 14766969 | ||
| Pubmed | Sox2 is required for development of taste bud sensory cells. | 5.20e-05 | 10 | 38 | 2 | 17015430 | |
| Pubmed | The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development. | 5.20e-05 | 10 | 38 | 2 | 21270765 | |
| Pubmed | Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. | 5.20e-05 | 10 | 38 | 2 | 20392836 | |
| Pubmed | Class 3 semaphorins negatively regulate dermal lymphatic network formation. | 6.35e-05 | 11 | 38 | 2 | 26319580 | |
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 15499555 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 19509466 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 32778568 | ||
| Pubmed | Meis1 is required for the maintenance of postnatal thymic epithelial cells. | 6.35e-05 | 11 | 38 | 2 | 24594519 | |
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 6.35e-05 | 11 | 38 | 2 | 27514653 | |
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 28714851 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 36136514 | ||
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 20346184 | ||
| Pubmed | Co-expression of Tbx6 and Sox2 identifies a novel transient neuromesoderm progenitor cell state. | 6.35e-05 | 11 | 38 | 2 | 29084802 | |
| Pubmed | Pias1 is essential for erythroid and vascular development in the mouse embryo. | 6.35e-05 | 11 | 38 | 2 | 27155222 | |
| Pubmed | 6.35e-05 | 11 | 38 | 2 | 27035511 | ||
| Pubmed | mSEL-1L deficiency affects vasculogenesis and neural stem cell lineage commitment. | 6.35e-05 | 11 | 38 | 2 | 28816361 | |
| Pubmed | Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7. | 7.62e-05 | 12 | 38 | 2 | 20947685 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 25839327 | ||
| Pubmed | Perivascular cells support folliculogenesis in the developing ovary. | 7.62e-05 | 12 | 38 | 2 | 36194632 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 19812329 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 22096573 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 23991118 | ||
| Pubmed | Impaired pancreatic development in Hif2-alpha deficient mice. | 7.62e-05 | 12 | 38 | 2 | 20678473 | |
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 16750824 | ||
| Pubmed | Defining the molecular pathologies in cloaca malformation: similarities between mouse and human. | 7.62e-05 | 12 | 38 | 2 | 24524909 | |
| Pubmed | Desmoglein 2 regulates cardiogenesis by restricting hematopoiesis in the developing murine heart. | 9.00e-05 | 13 | 38 | 2 | 34737300 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 33773996 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 23395391 | ||
| Pubmed | Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation. | 9.00e-05 | 13 | 38 | 2 | 26053665 | |
| Pubmed | Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit β5t. | 9.00e-05 | 13 | 38 | 2 | 21469133 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 15591414 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 24821700 | ||
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 25802403 | ||
| Pubmed | JAGGED1/NOTCH3 activation promotes aortic hypermuscularization and stenosis in elastin deficiency. | 9.00e-05 | 13 | 38 | 2 | 34990407 | |
| Pubmed | 9.00e-05 | 13 | 38 | 2 | 27991863 | ||
| Pubmed | Transcription factor TFCP2L1 patterns cells in the mouse kidney collecting ducts. | 9.00e-05 | 13 | 38 | 2 | 28577314 | |
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 9.00e-05 | 13 | 38 | 2 | 22723296 | |
| Pubmed | Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues. | 1.05e-04 | 14 | 38 | 2 | 21435445 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 18528438 | ||
| Pubmed | Sema3F (Semaphorin 3F) Selectively Drives an Extraembryonic Proangiogenic Program. | 1.05e-04 | 14 | 38 | 2 | 28729362 | |
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 23806616 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 27150575 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 1.42e-05 | 177 | 38 | 4 | chr15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 1.37e-04 | 120 | 38 | 3 | chr17q23 | |
| Cytoband | 15q21.2 | 2.67e-04 | 29 | 38 | 2 | 15q21.2 | |
| Cytoband | 17q23.3 | 2.86e-04 | 30 | 38 | 2 | 17q23.3 | |
| Cytoband | 15q21.3 | 3.90e-04 | 35 | 38 | 2 | 15q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p24 | 2.07e-03 | 81 | 38 | 2 | chr2p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q21 | 9.59e-03 | 178 | 38 | 2 | chr7q21 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.43e-04 | 20 | 25 | 2 | 736 | |
| GeneFamily | Immunoglobulin like domain containing | 2.32e-03 | 193 | 25 | 3 | 594 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.00e-02 | 110 | 25 | 2 | 420 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 4.12e-07 | 200 | 38 | 6 | M7505 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | 8.35e-06 | 432 | 37 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem.LN, TCRb CD44high CD122lo CD4, Lymph Node, avg-3 | 2.81e-05 | 348 | 37 | 6 | GSM538362_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.71e-05 | 126 | 37 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | 8.69e-05 | 849 | 37 | 8 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 9.36e-05 | 858 | 37 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | 9.81e-05 | 436 | 37 | 6 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2 | 2.44e-04 | 327 | 37 | 5 | GSM538380_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 2.48e-04 | 328 | 37 | 5 | GSM605756_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | 2.77e-04 | 336 | 37 | 5 | GSM538374_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 2.77e-04 | 336 | 37 | 5 | GSM605758_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 2.82e-04 | 183 | 37 | 4 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | 2.85e-04 | 338 | 37 | 5 | GSM605763_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 2.85e-04 | 338 | 37 | 5 | GSM403987_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 2.89e-04 | 339 | 37 | 5 | GSM399382_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | 3.29e-04 | 774 | 37 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.52e-04 | 79 | 37 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_1000_k2 | |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | 3.66e-04 | 357 | 37 | 5 | GSM403986_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 3.75e-04 | 359 | 37 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.Sp, CD4 TCRb CD44hi CD62Llo, Spleen, avg-3 | 3.75e-04 | 359 | 37 | 5 | GSM538371_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 3.81e-04 | 793 | 37 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 4.75e-04 | 210 | 37 | 4 | GSM403995_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_500 | 5.10e-04 | 384 | 37 | 5 | gudmap_kidney_e10.5_UretericTip_HoxB7_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 5.22e-04 | 386 | 37 | 5 | GSM605787_500 | |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 5.50e-04 | 20 | 37 | 2 | gudmap_kidney_e15.5_Podocyte_MafB_k3_200 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-08 | 192 | 37 | 6 | f14ee74ac3275601749a23c5efe39c2413a62e1a | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-08 | 192 | 37 | 6 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-07 | 170 | 37 | 5 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-07 | 174 | 37 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-07 | 174 | 37 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-07 | 174 | 37 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 6.25e-07 | 199 | 37 | 5 | 727122b6f4ca265d2826c9271b10a4215a9d45a3 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.41e-07 | 200 | 37 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-06 | 157 | 37 | 4 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-06 | 159 | 37 | 4 | f0611a7bf15e2f7dfe828dd247650a30b3d6d44d | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-06 | 163 | 37 | 4 | 5efecdd8a069a822bc9d35b407092925a865e629 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-06 | 163 | 37 | 4 | e04de78a52cc886623689a913f7852200a77605b | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-06 | 163 | 37 | 4 | 8509b87748ec460992ae6cedbb155e1c6f6e2e48 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-06 | 163 | 37 | 4 | 0d94a427f86e62aba12c397c6d7b8cd297f3a0e5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 165 | 37 | 4 | fee7f2f8d0e25c0d067adc73f8913721bd709a3e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 166 | 37 | 4 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-05 | 166 | 37 | 4 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | P28|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.13e-05 | 168 | 37 | 4 | 4ee59a6147bbe7e4a03cc2d6fe9d6c10b18a3a06 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 170 | 37 | 4 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 170 | 37 | 4 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 170 | 37 | 4 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-05 | 172 | 37 | 4 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 174 | 37 | 4 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 177 | 37 | 4 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 177 | 37 | 4 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 177 | 37 | 4 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.41e-05 | 178 | 37 | 4 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | droplet-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 179 | 37 | 4 | 006f2b6887b0f1f26e58bb11c919468b62bf4d62 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-05 | 180 | 37 | 4 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-05 | 182 | 37 | 4 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | droplet-Lung-21m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-05 | 185 | 37 | 4 | 9c907298166e3dd65b1d1e7673a1b8d01b492bd0 | |
| ToppCell | droplet-Lung-nan-21m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 185 | 37 | 4 | 43b7345a61e31099718c9cecf194b4e9884b904b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-05 | 187 | 37 | 4 | 5917bdfe84cf5941e21b415aebbab3090cc5d576 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-05 | 190 | 37 | 4 | 6847afca73e1b76c2e86187ccb1a164aefd8f17b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-05 | 190 | 37 | 4 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-05 | 190 | 37 | 4 | 2245f61ae0a720db21e29fcd4e910cf590d2655d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 193 | 37 | 4 | e4b440d50ae7391b26924778be6d9d53e0692449 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 193 | 37 | 4 | e523dc5751f6fdcd4fc1a62b1eecd43f6ae79da9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 193 | 37 | 4 | 1772f2ac217727de63c4a9303881b3a19a6bb0f0 | |
| ToppCell | PND14-Endothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | cee89d4340738f09d07a159cd6aeee4300776988 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | 32962060d80f3edffbe9f0ecad3000c3a9817865 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | 12496bc964d1c572241410524a89ca1a9fdb7e34 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | 46e36817fd1ed27af8013375214c38c9a9271640 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.98e-05 | 194 | 37 | 4 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | PND07-Endothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | d1080c86884916c22894b27994141463f5919812 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-05 | 194 | 37 | 4 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.02e-05 | 195 | 37 | 4 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.06e-05 | 196 | 37 | 4 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 2.06e-05 | 196 | 37 | 4 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 2.06e-05 | 196 | 37 | 4 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.06e-05 | 196 | 37 | 4 | 5bcb57c57d5da0440220a1133a96aa89407bd871 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-05 | 197 | 37 | 4 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 197 | 37 | 4 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-05 | 197 | 37 | 4 | 383d598ce3f8f5fc98bef3300e4cf7b6992aec9c | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-05 | 197 | 37 | 4 | 3cc4e56a77f96a43f9b5a24cf1b9524c927ef795 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 198 | 37 | 4 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.14e-05 | 198 | 37 | 4 | c26c909e95225440abdf558b1b858ffc06177000 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.14e-05 | 198 | 37 | 4 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Monocytes|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.14e-05 | 198 | 37 | 4 | 8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.14e-05 | 198 | 37 | 4 | 1259a6c14c85a406b7f4e9918ae148ee92b99f30 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 2.19e-05 | 199 | 37 | 4 | 8990a3d69e24cb3aaba9d6def3d0be9ee973436d | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 2.19e-05 | 199 | 37 | 4 | 96070b5ffcbab4952970f43b536969ddd2ca5d14 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.19e-05 | 199 | 37 | 4 | 73a98d19871ffbc3c631de330998d42e9afa6da2 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.23e-05 | 200 | 37 | 4 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.23e-05 | 200 | 37 | 4 | af5d4a3d735f38c6e07b5d7bd2965b0486632c4e | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.23e-05 | 200 | 37 | 4 | bbfbefd24cc070b010e787e08ff6bff4a7ee3f7c | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | 2f5b71e55c2de0e77fdae6667eb57f333acc6cd1 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.23e-05 | 200 | 37 | 4 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-TWIST2--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.23e-05 | 200 | 37 | 4 | b9ef0e11c8e22f2c9c926fd48fa2005ef8d22752 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.21e-04 | 142 | 37 | 3 | 77fd145c1c500d580f70ac4e54c3fd879ecf0ab3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.30e-04 | 144 | 37 | 3 | a9305d2499189f23b942775285be9fb260ce4214 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-8|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.55e-04 | 149 | 37 | 3 | 89705865e94360c1288ee98c5a6b381f3c6242b3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_dendritic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-04 | 150 | 37 | 3 | f4aed24b79e1be38abc7a1120256821601893d6d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.75e-04 | 153 | 37 | 3 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 3.14e-04 | 160 | 37 | 3 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.25e-04 | 162 | 37 | 3 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_naive|bone_marrow / Manually curated celltypes from each tissue | 3.25e-04 | 162 | 37 | 3 | 44832055b11a789e320c802aadb345e065defc8f | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.37e-04 | 164 | 37 | 3 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.37e-04 | 164 | 37 | 3 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 165 | 37 | 3 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.43e-04 | 165 | 37 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.49e-04 | 166 | 37 | 3 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 167 | 37 | 3 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.56e-04 | 167 | 37 | 3 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-04 | 167 | 37 | 3 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 168 | 37 | 3 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 168 | 37 | 3 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 168 | 37 | 3 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 3.62e-04 | 168 | 37 | 3 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-04 | 168 | 37 | 3 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.62e-04 | 168 | 37 | 3 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 168 | 37 | 3 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-04 | 168 | 37 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.62e-04 | 168 | 37 | 3 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 4.42e-05 | 56 | 36 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 4.91e-05 | 58 | 36 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | glycolipid transfer protein domain-containing protein 2 measurement | 5.18e-05 | 9 | 36 | 2 | EFO_0801643 | |
| Disease | Immunologic Deficiency Syndromes | 3.60e-04 | 23 | 36 | 2 | C0021051 | |
| Disease | Ischemic stroke, factor VII measurement | 5.76e-04 | 29 | 36 | 2 | EFO_0004619, HP_0002140 | |
| Disease | Thrombocytopenia | 5.76e-04 | 29 | 36 | 2 | C0040034 | |
| Disease | red blood cell density measurement | 6.27e-04 | 880 | 36 | 6 | EFO_0007978 | |
| Disease | venous thromboembolism, factor VII measurement | 9.90e-04 | 38 | 36 | 2 | EFO_0004286, EFO_0004619 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.39e-03 | 45 | 36 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.39e-03 | 45 | 36 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | lung adenocarcinoma, family history of lung cancer | 1.78e-03 | 51 | 36 | 2 | EFO_0000571, EFO_0006953 | |
| Disease | abdominal fat cell number | 1.81e-03 | 198 | 36 | 3 | EFO_0021534 | |
| Disease | episodic memory | 1.85e-03 | 52 | 36 | 2 | EFO_0004333 | |
| Disease | factor VII measurement | 2.06e-03 | 55 | 36 | 2 | EFO_0004619 | |
| Disease | response to carboplatin | 2.29e-03 | 58 | 36 | 2 | GO_0097328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YNTSCSKAYVNHMMS | 651 | Q6N043 | |
| TMIDALASCHMNYGT | 286 | P40394 | |
| SDCTVMNIAEHYMAS | 641 | P55884 | |
| NIMMYACINATKDSH | 561 | Q8TDJ6 | |
| VKMHCYMNSASGNVS | 61 | P40259 | |
| MQNMSIHTKTTSGYA | 406 | P05787 | |
| GNHKNRTNMTYEKMS | 381 | P41212 | |
| ADVMQKSSTCSFMYG | 56 | Q8NCM2 | |
| YGTMSYSTEMKNNCD | 401 | Q8NDZ0 | |
| MMHCQTLKDQPSAYS | 146 | P43897 | |
| SVMAMVEHSGNYTCK | 291 | P16284 | |
| KMMAAYNGGTSAAAA | 11 | Q9UBE8 | |
| KMISCSNHYNSVMPQ | 716 | Q9H422 | |
| DYKAASMHCQELMAT | 1296 | A2RRP1 | |
| SMHCQELMATGYPKS | 1301 | A2RRP1 | |
| VMKGQNVSMFCSHKN | 46 | Q7Z6M3 | |
| QAAAHMMRKTSCLQY | 181 | O75864 | |
| MGKMHKTCYNQEGIA | 291 | Q13936 | |
| YIGNSGMSSKMTHDC | 226 | Q9H2W1 | |
| KTYEGMMHSSCQQEM | 201 | O75608 | |
| TMNTKDPHVDCYTMS | 171 | Q17RS7 | |
| GHLANCMTQINAMTY | 141 | Q14469 | |
| MNKNISTPYSCAMHL | 81 | Q9NYK5 | |
| SAYIIKMNDGSCNHM | 291 | Q6ZMZ0 | |
| AFSHSEMQMINQYCK | 696 | Q99985 | |
| SASAYCNPSMQAEMH | 431 | Q5T5P2 | |
| ATMSLMNKNAYHNVT | 296 | Q9Y274 | |
| SSNIFKGSAVCMYSM | 331 | Q14563 | |
| AYIIKMNDGSCNHMT | 306 | Q9NV58 | |
| KGNSYQMMDHLDCAT | 491 | Q8TCT8 | |
| MMAQSKANGSHYALT | 1 | Q9NW97 | |
| MSMNNSHSYGNCLGM | 801 | Q2KHR2 | |
| SMHNKSATYSVGMQK | 496 | A8MT19 | |
| NAYHMSSTMKPNTKC | 656 | Q9BZW7 | |
| AMTYVQSHFCNSMID | 696 | Q6ZT12 | |
| HMRTHKDSFTYGCNM | 146 | O75362 | |
| SHTTESMCVGYMSAQ | 371 | Q9H6P5 | |
| MKMAVHNLYSASAGS | 21 | Q8N228 | |
| MDNKMTSCSYVAHER | 126 | Q8WVJ9 |